GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...
The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...
To bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to ...
The National Agency for the Control of AIDS (NACA), Global Network of Young People Living with HIV (Y+ Global), and the Joint ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle ...
LGBTQ group says Uganda has lost potentially up to $1.6 billion in GDP following the passage of a law criminalizing ...
Despite high rates of untreated osteoporosis and previous fractures among menopausal women in Zimbabwe -- especially among those living with human immunodeficiency virus (HIV) -- the FRAX® tool ...
Nomonde Ngema, 21, who was born with HIV, not only tackles the stigma on TikTok by sharing her journey, she also takes on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback